Modern Review,Total Synthesis

The complete synthesis of the bicyclic ring of a mutacin analog represents a significant advancement in the field of organic chemistry, particularly in the challenging area of peptide synthesis. This breakthrough, primarily reported by K. Kirichenko and colleagues in 2019, marks the first successful chemical construction of the bicyclic C/D ring system found in mutacin analogs, specifically referencing the MU1140 analog. This achievement has profound implications for understanding and potentially harnessing the biological activities of these complex molecules.

Mutacins are a class of ribosomally synthesized and post-translationally modified peptides (RiPPs) that possess unique structural features, including the characteristic bicyclic ring systems. These structures are crucial for their biological function, often involving antimicrobial or other bioactive properties. The synthesis of such intricate molecular architectures has historically been a formidable task for chemists.

The pioneering work in the complete chemical synthesis of the bicyclic C/D ring of a MU1140 analog utilized a sophisticated strategy involving orthogonally protected lanthionines. Lanthionine residues are key components in the formation of the thioether bridges that define the bicyclic structure in mutacins. The use of orthogonal protection allows for selective manipulation of different functional groups during the synthetic process, a critical requirement for building complex molecules step-by-step. Furthermore, the researchers employed solid-phase peptide synthesis (SPPS), a widely used technique that enables the efficient assembly of peptide chains on a solid support, facilitating purification and reaction manipulation.

This synthesis not only provides a method for creating a specific mutacin analogue but also lays the groundwork for the Total Synthesis of other related compounds. The ability to construct the bicyclic ring system with high fidelity opens doors to exploring structure-activity relationships and designing novel peptides with tailored properties.

Beyond the specific achievements with mutacin analogs, the broader field of bicyclic ring synthesis has seen continuous innovation. Various strategies have been developed for constructing diverse bicyclic frameworks, including those that do not rely on ring junction formation, as explored in studies on Cycloaraneosene and Ophiobolin M. Other approaches have focused on creating bicyclic organo-peptide hybrids via oxime ligation, incorporating non-peptidic elements into peptide backbones. Additionally, novel methodologies like tandem intermolecular Michael addition–intramolecular aldol condensation have been developed for the efficient synthesis of bicyclo[2.2.2]oct-5-en-2-ones. The synthesis of aza bicyclic enones via anionic cyclization represents another significant contribution to constructing complex heterocyclic systems.

The research on the complete synthesis of the bicyclic ring of a mutacin analog is a testament to the power of modern synthetic chemistry. By overcoming the challenges associated with constructing the fused C/D rings of mutacin 1140, scientists have not only validated a crucial structural motif but also paved the way for the development of new therapeutic agents and biochemical probes. The ongoing exploration of bicyclic ring systems and their synthetic routes continues to expand the toolkit available to chemists, promising further breakthroughs in molecular design and discovery.